Related Experiment Video
Updated: Dec 24, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Impact of bleeding events after percutaneous coronary intervention in patients on hemodialysis
Takahiro Hayashi1, Koki Shishido2, Shohei Yokota1
1Department of Cardiology, Shonan Kamakura General Hospital, Okamoto 1370-1, Kamakura, 247-8533, Japan.
Insights
Bleeding events after percutaneous coronary intervention (PCI) significantly increase mortality in hemodialysis patients. This study highlights the critical link between post-PCI bleeding and survival in this vulnerable population.
Area of Science:
- Nephrology
- Cardiology
- Clinical Research
Background:
- Coronary artery disease (CAD) is prevalent in patients undergoing hemodialysis.
- Percutaneous coronary intervention (PCI) is a common treatment for CAD, but carries a high risk of bleeding in dialysis patients.
Purpose of the Study:
- To investigate the impact of bleeding events following PCI on all-cause mortality in patients on hemodialysis.
- To analyze the association between bleeding complications and survival rates after PCI with drug-eluting stents (DES).
Main Methods:
- A retrospective study of 386 hemodialysis patients who underwent PCI with DES between 2004 and 2017.
- Assessment of bleeding events using the Thrombolysis in Myocardial Infarction (TIMI) bleeding definition within 24 months post-PCI.
- Comparison of mortality rates between patients with and without bleeding events.
Main Results:
- A total of 42 patients (10.9%) experienced bleeding events, with 71.4% classified as TIMI major bleeding.
- Patients with bleeding events exhibited significantly higher all-cause mortality (survival rate 55.1%) compared to those without bleeding events (survival rate 81.5%).
- The log-rank test indicated a statistically significant difference in survival (p < 0.001).
Conclusions:
- Bleeding events occurring after PCI with DES are strongly associated with increased all-cause mortality in hemodialysis patients.
- This study provides novel insights into the significant relationship between bleeding complications and mortality specifically within the hemodialysis population.
- The findings underscore the importance of managing bleeding risk in dialysis patients undergoing PCI.
Abstract:
Coronary artery disease is common in patients on dialysis; there is a high rate of bleeding events after percutaneous coronary intervention (PCI) in such patients. We investigated the impact of bleeding events after PCI on mortality in patients on hemodialysis. We included 386 consecutive hemodialysis patients who underwent PCI using a drug-eluting stent (DES) between September 2004 and December 2017 in our hospital, and investigated the impact of bleeding events on all-cause mortality after PCI. Bleeding events were assessed by the Thrombolysis in Myocardial Infarction (TIMI) bleeding definition within 24 months after PCI. A total of 42 patients experienced bleeding events. Of these, 30 patients (71.4%) had TIMI major bleeding events and 12 patients (28.6%) had TIMI minor bleeding events. Patients with bleeding events had significantly higher mortality than patients without bleeding events (survival rate, 55.1% vs 81.5%, log-rank: p < 0.001). These results suggest that bleeding events after PCI with a DES are notably associated with all-cause mortality among patients on hemodialysis. This is the first report about relationship between bleeding events and mortality to focus on patients on hemodialysis.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Cardiac Catheterization I: Pre-Procedure Overview
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis III: Nursing Management
Hemodialysis I: Introduction
Cardiac Catheterization IV: Nursing Management

